James L. Fisher

TL;DR: Global health has steadily improved over the past 30 years as measured by age-standardised DALY rates, and there has been a marked shift towards a greater proportion of burden due to YLDs from non-communicable diseases and injuries.

TL;DR: The largest declines in risk exposure from 2010 to 2019 were among a set of risks that are strongly linked to social and economic development, including household air pollution; unsafe water, sanitation, and handwashing; and child growth failure.

TL;DR: A “state of the science” review of current research into causes and risk factors for gliomas in adults is provided.

TL;DR: The Global Burden of Disease (GBD) study as discussed by the authors has been used to describe cancer burden for 29 cancer groups in 195 countries from 1990 through 2017 to provide data needed for cancer control planning, including cancer incidence, mortality, years lived with disability, years of life lost, and disability-adjusted life years (DALYs).

TL;DR: Preliminary evidence points to a lower glioma risk among people with allergic conditions and high levels of serum IgE, and studies of polymorphisms of genetic pathways with strong prior hypotheses are planned, and whole-genome scans are being proposed to study high-risk families and case–control series.